NO171016C - Analogifremgangsmaate ved fremstilling av terapeutisk aktive quinolin-derivater - Google Patents

Analogifremgangsmaate ved fremstilling av terapeutisk aktive quinolin-derivater

Info

Publication number
NO171016C
NO171016C NO884599A NO884599A NO171016C NO 171016 C NO171016 C NO 171016C NO 884599 A NO884599 A NO 884599A NO 884599 A NO884599 A NO 884599A NO 171016 C NO171016 C NO 171016C
Authority
NO
Norway
Prior art keywords
preparation
quinoline derivatives
therapeutic active
analogy procedure
active quinoline
Prior art date
Application number
NO884599A
Other languages
English (en)
Norwegian (no)
Other versions
NO884599D0 (no
NO884599L (no
NO171016B (no
Inventor
Jun-Ichi Matsumoto
Akira Minamida
Masahiro Fujita
Tohru Hirose
Junji Nakano
Shinichi Nakamura
Original Assignee
Dainippon Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dainippon Pharmaceutical Co filed Critical Dainippon Pharmaceutical Co
Publication of NO884599D0 publication Critical patent/NO884599D0/no
Publication of NO884599L publication Critical patent/NO884599L/no
Publication of NO171016B publication Critical patent/NO171016B/no
Publication of NO171016C publication Critical patent/NO171016C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
NO884599A 1987-10-16 1988-10-14 Analogifremgangsmaate ved fremstilling av terapeutisk aktive quinolin-derivater NO171016C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP26244187 1987-10-16
JP10884088 1988-04-30

Publications (4)

Publication Number Publication Date
NO884599D0 NO884599D0 (no) 1988-10-14
NO884599L NO884599L (no) 1989-04-17
NO171016B NO171016B (no) 1992-10-05
NO171016C true NO171016C (no) 1993-01-13

Family

ID=26448650

Family Applications (1)

Application Number Title Priority Date Filing Date
NO884599A NO171016C (no) 1987-10-16 1988-10-14 Analogifremgangsmaate ved fremstilling av terapeutisk aktive quinolin-derivater

Country Status (16)

Country Link
US (1) US5013841A (zh)
EP (1) EP0312085B1 (zh)
KR (1) KR930006774B1 (zh)
CN (1) CN1021967C (zh)
DE (1) DE3880953T2 (zh)
DK (1) DK573788A (zh)
ES (1) ES2054762T3 (zh)
FI (1) FI884752A (zh)
HU (1) HU204521B (zh)
IL (1) IL88003A (zh)
NO (1) NO171016C (zh)
NZ (1) NZ226574A (zh)
PH (1) PH25530A (zh)
PT (1) PT88769A (zh)
RU (2) RU1780534C (zh)
YU (3) YU46647B (zh)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL88003A (en) * 1987-10-16 1992-11-15 Dainippon Pharmaceutical Co Quinoline derivatives,their preparation and pharmaceutical compositions containing them
US5262417A (en) * 1988-12-06 1993-11-16 The Upjohn Company Antibacterial quinolone compounds
DE69132256T2 (de) 1990-04-18 2001-01-25 Procter & Gamble Pharma Antimikrobielle chinolonyl-lactame
DE4019023A1 (de) * 1990-06-14 1991-12-19 Bayer Ag Verfahren zur herstellung von chinolincarbonsaeuren
TW252107B (zh) * 1993-08-27 1995-07-21 Hokuriku Pharmacetical Co Ltd
CA2467321A1 (en) * 2004-05-14 2005-11-14 Paul J. Santerre Polymeric coupling agents and pharmaceutically-active polymers made therefrom
FR2916446B1 (fr) * 2007-05-24 2009-08-21 Biocodex Sa Nouveau procede de synthese de fluoroquinolones
WO2019148293A1 (en) 2018-02-02 2019-08-08 Interface Biologics, Inc. Glass formulations comprising steroid dimers and uses thereof
MX2022013665A (es) 2020-05-01 2022-11-30 Ripple Therapeutics Corp Composiciones y metodos heterodimeros para el tratamiento de trastornos oculares.

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3142854A1 (de) * 1981-10-29 1983-05-11 Bayer Ag, 5090 Leverkusen 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7-piperazino-chinolin-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
DE3248506A1 (de) * 1982-12-29 1984-07-05 Bayer Ag, 5090 Leverkusen 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7(alkyl-1-piperazinyl)-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
AU594983B2 (en) * 1985-10-29 1990-03-22 Dainippon Pharmaceutical Co. Ltd. Novel quinoline derivatives and processes for preparation thereof
DE3542002A1 (de) * 1985-11-28 1987-06-04 Bayer Ag 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7- (1-piperazinyl)-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
US4668680A (en) * 1985-12-12 1987-05-26 Warner-Lambert Company 5-amino-6,8-difluoroquinolones as antibacterial agents
JPS62215572A (ja) * 1986-03-17 1987-09-22 Kyorin Pharmaceut Co Ltd キノロンカルボン酸誘導体
EP0242789A3 (en) * 1986-04-25 1990-09-05 Dainippon Pharmaceutical Co., Ltd. Novel quinoline derivates and processes for preparation thereof
DE3711193A1 (de) * 1987-04-02 1988-10-13 Bayer Ag 5-substituierte chinolon- und naphthyridoncarbonsaeure-derivate
US5591744A (en) * 1987-04-16 1997-01-07 Otsuka Pharmaceutical Company, Limited Benzoheterocyclic compounds
IL88003A (en) * 1987-10-16 1992-11-15 Dainippon Pharmaceutical Co Quinoline derivatives,their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
KR930006774B1 (ko) 1993-07-23
DK573788D0 (da) 1988-10-14
PT88769A (pt) 1989-07-31
YU46703B (sh) 1994-04-05
DK573788A (da) 1989-04-17
FI884752A0 (fi) 1988-10-14
RU1830067C (ru) 1993-07-23
RU1780534C (ru) 1992-12-07
AU2375488A (en) 1989-04-20
IL88003A0 (en) 1989-06-30
US5013841A (en) 1991-05-07
NO884599D0 (no) 1988-10-14
ES2054762T3 (es) 1994-08-16
HU204521B (en) 1992-01-28
DE3880953T2 (de) 1993-10-14
EP0312085B1 (en) 1993-05-12
HUT49342A (en) 1989-09-28
YU199089A (en) 1990-04-30
FI884752A (fi) 1989-04-17
EP0312085A3 (en) 1990-05-30
PH25530A (en) 1991-07-24
YU46684B (sh) 1994-04-05
NO884599L (no) 1989-04-17
CN1021967C (zh) 1993-09-01
EP0312085A2 (en) 1989-04-19
DE3880953D1 (de) 1993-06-17
KR890006620A (ko) 1989-06-14
YU46647B (sh) 1994-01-20
IL88003A (en) 1992-11-15
YU192288A (en) 1990-04-30
NO171016B (no) 1992-10-05
AU619214B2 (en) 1992-01-23
CN1033996A (zh) 1989-07-19
YU198989A (en) 1990-04-30
NZ226574A (en) 1991-07-26

Similar Documents

Publication Publication Date Title
NO171506C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive adenosin-derivater
NO170726C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive quinolinderivater
NO171638C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolin-derivater
NO170483C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive tetrahydronaftalin- og indanderivater
NO168770C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater
NO171788C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fosfinsyrederivater
NO170727C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzopyran-derivater
NO170629C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive dikloranilin-derivater
NO159089C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive glutarimidderivater.
NO820479L (no) Fremgangsmaate for fremstilling av terapeutisk aktive carbostyrilderivater
NO169014C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive distamycinderivater
NO169438C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tetrazolforbindelser
NO167916C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiolaktam-n-eddiksyrederivater
NO167026C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater
NO168355C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater
NO165841C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive heteroaryl-3-okso-propannitril-derivater.
NO171507C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive nukleotidderivater
NO172489C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive imidazolderivater
NO168299C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive alkansulfonanilid-derivater
NO170976C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenylbuten-syrederivater
NO170582C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aryl-piperazinyl-alkylenfenyl-heterocykliske forbindelser
NO170021C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 3-propenylcefem-derivater
NO168037C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive purin-derivater.
NO169069C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-alkoksy-2-aminopropylaminderivater
NO169007C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive uridinderivater